- Home
- LYEL vs CHMG Comparison
LYEL vs CHMG Comparison
Compare LYEL & CHMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYEL
- CHMG
- Stock Information
- Founded
- LYEL 2018
- CHMG 1833
- Country
- LYEL United States
- CHMG United States
- Employees
- LYEL N/A
- CHMG N/A
- Industry
- LYEL Biotechnology: Pharmaceutical Preparations
- CHMG Major Banks
- Sector
- LYEL Health Care
- CHMG Finance
- Exchange
- LYEL Nasdaq
- CHMG Nasdaq
- Market Cap
- LYEL 207.7M
- CHMG 239.3M
- IPO Year
- LYEL 2021
- CHMG N/A
- Fundamental
- Price
- LYEL $12.82
- CHMG $52.58
- Analyst Decision
- LYEL Sell
- CHMG Hold
- Analyst Count
- LYEL 2
- CHMG 3
- Target Price
- LYEL $15.00
- CHMG $56.33
- AVG Volume (30 Days)
- LYEL 25.5K
- CHMG 7.2K
- Earning Date
- LYEL 11-06-2025
- CHMG 10-21-2025
- Dividend Yield
- LYEL N/A
- CHMG 2.43%
- EPS Growth
- LYEL N/A
- CHMG N/A
- EPS
- LYEL N/A
- CHMG 2.38
- Revenue
- LYEL $60,000.00
- CHMG $82,641,000.00
- Revenue This Year
- LYEL N/A
- CHMG N/A
- Revenue Next Year
- LYEL N/A
- CHMG $32.65
- P/E Ratio
- LYEL N/A
- CHMG $22.13
- Revenue Growth
- LYEL 11.11
- CHMG N/A
- 52 Week Low
- LYEL $7.65
- CHMG $40.71
- 52 Week High
- LYEL $32.00
- CHMG $55.73
- Technical
- Relative Strength Index (RSI)
- LYEL 64.71
- CHMG 50.86
- Support Level
- LYEL $12.59
- CHMG $52.31
- Resistance Level
- LYEL $13.50
- CHMG $53.49
- Average True Range (ATR)
- LYEL 0.67
- CHMG 0.82
- MACD
- LYEL 0.18
- CHMG -0.10
- Stochastic Oscillator
- LYEL 76.87
- CHMG 10.98
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About CHMG Chemung Financial Corp
Chemung Financial Corp is a bank holding firm. Through its subsidiaries, the company provides various financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds, and brokerage services, among others. The company's reportable segments are Core Banking, Wealth Management (WMG) services, and Holding company and CFS. Maximum revenue is generated from the Core Banking segment, which derives revenue by attracting deposits from the general public and using such funds to originate different types of loans, and to invest in securities. The Wealth Management (WMG) services segment provides trust and investment advisory services to clients.